Caregiver Warning - Of Import Update On Namenda (Memantine)
Forest Laboratories, Inc. has announced that it plans to discontinue the sale of NAMENDA® (memantine HCl) v mg as well as 10 mg tablets effective August 15, 2014.
+
As far equally I tin move state to a greater extent than than 60 pct (60 percent) of all Alzheimer's patients are currently beingness treated alongside the combination of Namenda as well as Aricept (Donepezil, or unopen to other acetylcholinesterase inhibitor).
Baca Juga
Beginning inward August, Forest Laboratories plans to discontinue Namenda tablets, as well as instead volition endure offering a novel formulation NAMENDA XR®.
So the intelligence that follows inward the press issue below should endure read carefully as well as shared inward back upward groups worldwide.
I would advise that Alzheimer's caregivers bring this data to their physician or neurologist now, as well as starting fourth dimension discussing the implications of this alter if y'all accept non already done this.
I am non a Dr. only I accept written many times that I beleive my woman bring upward did create goodness from beingness on the combination therapy (Arciept as well as Namenda). See the related content below.
| Subscribe to the |
Forest Laboratories to Discontinue NAMENDA® Tablets, Focus on Once-Daily NAMENDA XR®
Decision Supported past times Positive Reception of NAMENDA XR past times Physicians, Patients, as well as Caregivers
Forest Laboratories, Inc. (NYSE:FRX), a leading, fully integrated, specialty pharmaceutical society largely focused on the States of America market, today announced that it plans to discontinue the sale of NAMENDA® (memantine HCl) v mg as well as 10 mg tablets effective August 15, 2014.
Forest has notified the U.S. Food as well as Drug Administration of this decision.
The oral solution of NAMENDA as well as once-daily NAMENDA XR® (memantine HCl) extended-release capsules volition proceed to endure available.
Both NAMENDA as well as NAMENDA XR are indicated for the handling of moderate to severe Alzheimer’s disease.
“NAMENDA XR offers of import benefits, including convenient, once-daily dosing, which is especially meaningful for this patient population as well as their caregivers. Our conclusion to focus on NAMENDA XR is supported past times these benefits equally good equally the positive feedback we’ve received from physicians as well as caregivers since the launch of NAMENDA XR,” said Marco Taglietti, MD, Chief Medical officeholder as well as EVP, Drug Development as well as Research of Forest. “The conversion too allows us to streamline our resources as well as explore innovative novel compounds that may endure effective for the handling of Alzheimer’s disease, including the fixed-dose combination of NAMENDA XR as well as donepezil, which is nether development.”Importantly, physicians tin move switch patients from NAMENDA to NAMENDA XR the rattling adjacent twenty-four hours without titration, equally outlined inward the FDA-approved bundle insert. In add-on to its convenient dosing, NAMENDA XR capsules tin move endure opened as well as the contents sprinkled on applesauce for patients who accept difficulty swallowing pills.
“Given the day-to-day challenges of caring for individual alongside Alzheimer’s disease, there is a postulate for treatments that simplify a patient’s daily regimen as well as may aid caregivers cope their loved ones’ needs,” said Gustavo Alva, MD, Neuropsychiatrist as well as Medical Director at ATP Clinical Research inward Costa Mesa, CA. “For many families, NAMENDA XR is already fulfilling this postulate equally a once-a-day handling alternative.”Forest sponsored a third-party survey that included 250 physicians treating Alzheimer’s patients as well as 250 caregivers of Alzheimer’s patients.
Physicians surveyed responded that NAMENDA XR i time daily direction was of import inward their conclusion to prescribe the medication. Also, a bulk of caregivers responded that they were satisfied alongside the i time daily dosing of NAMENDA XR.
Dr. Taglietti farther noted: “Forest has provided effective treatments as well as educational activity to the Alzheimer’s community for the past times decade, as well as nosotros rest fully committed to delivering products that tin move better the lives of patients as well as their loved ones.”
Forest is actively communicating alongside healthcare providers, pharmacists, patients, as well as caregivers to notify them of the discontinuation of NAMENDA as well as the continued availability of NAMENDA XR.
Patients as well as caregivers alongside questions tin move telephone call upward Forest’s dedicated toll-free number, 1-844-TREAT-AD.
About NAMENDA XR®
NAMENDA XR (memantine HCl) extended issue capsules are a higher dose, once-daily formulation of NAMENDA immediate issue indicated for the handling of moderate to severe dementia of the Alzheimer’s type. Its machinery of activeness focuses on the glutamate pathway, a target for the handling of Alzheimer's disease. The efficacy as well as security of NAMENDA XR was established inward a 24 week, randomized, double-blind, placebo-controlled case of 677 outpatients on a stable dose of acetylcholinesterase inhibitors (AChEl).
NAMENDA XR 28 mg summation an AChEI demonstrated statistically important improvement inward noesis as well as global business office compared to placebo summation an AChEI. Cognition was measured past times the Severe Impairment Battery Scale (2.6 unit of measurement hateful difference). Global business office was measured past times the Clinician’s Interview-Based Impression of Change Scale (0.3. unit of measurement hateful difference).
There is no evidence that NAMENDA XR or an AChEI prevents or slows the underlying affliction procedure inward patients alongside Alzheimer’s disease.
Questions most Namenda XR, Risk
Caregiver Companion Symptom Recognition Tool
Taking NamendaXR
Forest Laboratories (NYSE: FRX) is a leading, fully integrated, specialty pharmaceutical society largely focused on the States of America market. The Company is headquartered inward New York, NY. To larn more, see www.FRX.com.
Related Articles inward the
- Does the Combination of Aricept as well as Namenda Slow the Rate of Decline inward Alzheimer's Patients
- Combination Therapy for Alzheimer's Disease (Aricept as well as Namenda)
- Aricept as well as Namenda from Day One -- This is my Belief
- Rewiring My Brain as well as Stepping into Alzheimer's World
- Alzheimer's, Your Brain, as well as Adaptability
- Problems alongside Balance, Walking, Falling Can Be an Early Sign of Dementia
- Dementia as well as the Eight Types of Dementia